Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate

Abstract This study aimed to compare the serum lipid profiles between tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) in the long-term treatment of chronic hepatitis B (CHB). We analyzed data from treatment-naïve CHB patients administered with TDF or TAF, collected from electroni...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Shenglong Lin, Wanlong Huang, Ziyuan Liao, Huaxi Ma, Wenjun Wu, Minghua Lin, Defu Huang, Haibing Gao
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Portfolio 2024-11-01
Serier:	Scientific Reports
Fag:	Serum lipid profiles Tenofovir Disoproxil Fumarate (TDF) Tenofovir Alafenamide (TAF) Chronic Hepatitis B (CHB) Dyslipidemia
Online adgang:	https://doi.org/10.1038/s41598-024-78656-0
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!